Unknown

Dataset Information

0

De novo asymmetric synthesis of fridamycin E.


ABSTRACT: A de novo asymmetric synthesis of (R)- and (S)-fridamycin E has been achieved. The entirely linear route required only nine steps from commercially available starting materials (16% overall yield). Key transformations included a Claisen rearrangement, a Sharpless dihydroxylation and a cobalt-catalyzed epoxide carbonylation to give a ?-lactone intermediate. Antibacterial activities were determined for both enantiomers using two strains of E. coli, with the natural (R)-enantiomer showing significant inhibition against a Gram-(+)-like imp strain (MIC = 8 ?M).

SUBMITTER: Chen Q 

PROVIDER: S-EPMC3476477 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

De novo asymmetric synthesis of fridamycin E.

Chen Qian Q   Mulzer Michael M   Shi Pei P   Beuning Penny J PJ   Coates Geoffrey W GW   O'Doherty George A GA  

Organic letters 20111122 24


A de novo asymmetric synthesis of (R)- and (S)-fridamycin E has been achieved. The entirely linear route required only nine steps from commercially available starting materials (16% overall yield). Key transformations included a Claisen rearrangement, a Sharpless dihydroxylation and a cobalt-catalyzed epoxide carbonylation to give a β-lactone intermediate. Antibacterial activities were determined for both enantiomers using two strains of E. coli, with the natural (R)-enantiomer showing significa  ...[more]

Similar Datasets

| S-EPMC2531217 | biostudies-literature
| S-EPMC9419992 | biostudies-literature
| S-EPMC2615677 | biostudies-literature
| S-EPMC9410570 | biostudies-literature
| S-EPMC2546502 | biostudies-literature
| S-EPMC2527507 | biostudies-literature
| S-EPMC2529256 | biostudies-literature
| S-EPMC3059258 | biostudies-literature
| S-EPMC2515821 | biostudies-literature
| S-EPMC3686126 | biostudies-literature